Home / IZOZF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does IZOZF make money? Does IZOZF have pricing power? What's the Earnings Whisper? Will IZOZF profit more as the business scales? What is IZOZF's management track record? Is IZOZF's current price justified?

Izotropic Corporation

$0.16 -$0.06 (-26.67%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$0.15

Day Range

$0.15$0.16

Year Range

$0.1$0.37

Market Cap

11M

AVG Volume

19.38K

Trailing/Forward PE

-6.38/3.74

PEG ratio

-0.18

Dividend Yield

Next Earnings Date

Primary Exchange

Other OTC

Revenue (CAD)

IZOZF Revenue (CAD) by year
Period	Revenue (CAD)
2026	0
2025	0
2024	0
2023	0
2022	0
2021	0
2020	0
2019	0
2018	359
2017	0

Net Income (CAD)

IZOZF Net Income (CAD) by year
Period	Net Income (CAD)
2026	-2.18M
2025	-3.09M
2024	-1.56M
2023	-5.84M
2022	-6.67M
2021	-5.1M
2020	-1.16M
2019	-398.54K
2018	-730.13K
2017	-113

Operating Income (CAD)

IZOZF Operating Income (CAD) by year
Period	Operating Income (CAD)
2026	-1.43M
2025	-3.04M
2024	-1.63M
2023	-5.39M
2022	-6.62M
2021	-5.1M
2020	-1.16M
2019	-398.54K
2018	-705.4K
2017	-85

EBITDA (CAD)

IZOZF EBITDA (CAD) by year
Period	EBITDA (CAD)
2026	-1.42M
2025	-2.75M
2024	-1.56M
2023	-5.37M
2022	-6.64M
2021	-5.1M
2020	-1.15M
2019	-398.53K
2018	-700.87K
2017	-52.12K

Cash Flows (CAD)

IZOZF Cash Flows (CAD) by year
Period	Cash Flows (CAD)
2026	-790.08K
2025	-637.37K
2024	-593.57K
2023	-3.3M
2022	-4.79M
2021	-3.08M
2020	-987.43K
2019	-442.61K
2018	-610.6K
2017	-55.16K

EPS (CAD)

IZOZF EPS (CAD) by year
Period	EPS (CAD)
2026	-0.03
2025	-0.05
2024	-0.03
2023	-0.12
2022	-0.15
2021	-0.15
2020	-0.05
2019	-0.02
2018	-0.04
2017	-0

Expenses (CAD)

IZOZF Expenses (CAD) by year
Period	Expenses (CAD)
2026	1.34M
2025	2.03M
2024	1.51M
2023	5.17M
2022	6.26M
2021	4.48M
2020	980.35K
2019	263.87K
2018	532.1K
2017	85

Cash & Debt (CAD)

IZOZF Cash & Debt (CAD) by year
Period	Cash & Debt (CAD)
2026	219.64K
2025	274.11K
2024	38.6K
2023	165.69K
2022	1.86M
2021	4.06M
2020	613.57K
2019	308.5K
2018	471.94K
2017	149.44K

Debt ratios

IZOZF Debt ratios by year
Period	Debt ratios
2026	-0.26
2025	-0.15
2024	-0.11
2023	-0.11
2022	-0.01
2021	0.55
2020	0.27

Margins

IZOZF Margins by year
Period	Margins
2018	-5.85%

Return on Capital

IZOZF Return on Capital by year
Period	Return on Capital
2026	38.85%
2025	63.58%
2024	40.59%
2023	189.84%
2022	1779.84%
2021	-112.83%
2020	-163.43%
2019	-125.78%
2018	-179.06%
2017	0.17%

Shares Outstanding

IZOZF Shares Outstanding by year
Period	Shares Outstanding
2026	69.23M
2025	62.96M
2024	55M
2023	51.86M
2022	44.84M
2021	42.01M
2020	27.53M
2019	22.84M
2018	11.35M
2017	22.5M

Book Value Per Share (CAD)

IZOZF Book Value Per Share (CAD) by year
Period	Book Value Per Share (CAD)
2026	-0.08
2025	-0.08
2024	-0.07
2023	-0.06
2022	-0.01
2021	0.11
2020	0.03
2019	0.01
2018	0.04
2017	-0

Total Assets (CAD)

IZOZF Total Assets (CAD) by year
Period	Total Assets (CAD)
2026	439.63K
2025	414.73K
2024	232.38K
2023	442.11K
2022	2.27M
2021	4.69M
2020	777.21K
2019	339.06K
2018	491.64K
2017	149.69K

Free Cash Flow Yield

IZOZF Free Cash Flow Yield by year
Period	Free Cash Flow Yield
Sep 26	-5.41%
Sep 26	-5.16%
Aug 26	-4.71%
Aug 26	-4.88%
Aug 26	-4.72%
Aug 26	-4.82%
Jul 26	-4.77%
Jul 26	-5.17%
Jul 26	-5.46%
Jul 26	-5.13%
Jul 26	-4.99%
Jun 26	-5.15%
Jun 26	-5.37%
Jun 26	-5.42%
Jun 26	-4.86%
May 26	-4.95%
May 26	-5.3%
May 26	-4.55%
May 26	-4.54%
May 26	-4.37%
Apr 26	-5.35%
Apr 26	-6.29%
Apr 26	-6.47%
Apr 26	-6.54%
Mar 26	-6.2%
Mar 26	-6.37%
Mar 26	-6.65%
Mar 26	-6.79%
Feb 26	-6.19%
Feb 26	-6.71%
Feb 26	-6.51%
Feb 26	-6.74%
Jan 26	-6.01%
Jan 26	-4.24%
Jan 26	-3.87%
Jan 26	-3.55%
Jan 26	-3.6%
Dec 25	-3.62%
Dec 25	-3.77%
Dec 25	-3.49%
Dec 25	-3.51%
Nov 25	-3.34%
Nov 25	-3.17%
Nov 25	-2.8%
Nov 25	-2.6%
Oct 25	-2.34%
Oct 25	-2.17%
Oct 25	-2.83%
Oct 25	-2.73%
Oct 25	-2.64%
Sep 25	-2.57%
Sep 25	-2.52%
Sep 25	-3.01%
Sep 25	-3.17%
Aug 25	-3.51%
Aug 25	-3.25%
Aug 25	-3.41%
Aug 25	-3.08%
Aug 25	-3.73%
Jul 25	-2.81%
Jul 25	-3.07%
Jul 25	-2.8%
Jul 25	-2.87%
Jun 25	-3.08%
Jun 25	-2.86%
Jun 25	-2.47%
Jun 25	-2.73%
May 25	-2.27%
May 25	-2.3%
May 25	-2.52%
May 25	-2.71%
May 25	-2.71%
Apr 25	-1.94%
Apr 25	-1.92%
Apr 25	-2.19%
Apr 25	-1.63%
Mar 25	-1.6%
Mar 25	-1.32%
Mar 25	-1.19%
Mar 25	-1.49%
Feb 25	-1.41%
Feb 25	-1.71%
Feb 25	-1.76%
Feb 25	-1.68%
Jan 25	-2.39%
Jan 25	-4.85%
Jan 25	-5.7%
Jan 25	-6.44%
Jan 25	-10.49%
Dec 24	-15.46%
Dec 24	-21.15%
Dec 24	-26.1%
Dec 24	-31.87%
Nov 24	-18.65%
Nov 24	-22.71%
Nov 24	-18.44%
Nov 24	-16.02%
Nov 24	-15.66%
Oct 24	-16.55%
Oct 24	-24.37%

Price to Book

IZOZF Price to Book by year
Period	Price to Book
Jul 22	83.2
Jul 22	79.81
Jul 22	79.94
Jul 22	70.6
Jun 22	77.71
Jun 22	92.04
Jun 22	110.58
Jun 22	114.68
May 22	109.13
May 22	109.38
May 22	126.87
May 22	139.5
Apr 22	19.26
Apr 22	19.35
Apr 22	17.95
Apr 22	19.17
Apr 22	17.66
Mar 22	18.45
Mar 22	17.61
Mar 22	18.31
Mar 22	19.37
Feb 22	19.86
Feb 22	19.76
Feb 22	20.09
Feb 22	19.78
Jan 22	8.1
Jan 22	9.12
Jan 22	9.63
Jan 22	9.48
Dec 21	10.34
Dec 21	10.11
Dec 21	10.13
Dec 21	10.77
Dec 21	11.07
Nov 21	10.95
Nov 21	10.68
Nov 21	9.95
Nov 21	9.97
Oct 21	11.14
Oct 21	9.54
Oct 21	11.19
Oct 21	9.04
Oct 21	8.01
Sep 21	7.52
Sep 21	7.07
Sep 21	7.79
Sep 21	7.8
Aug 21	6.98
Aug 21	6.68
Aug 21	6.63
Aug 21	6.51
Jul 21	6.38
Jul 21	4.32
Jul 21	4.28
Jul 21	4.59
Jul 21	4.66
Jun 21	4.64
Jun 21	4.84
Jun 21	5.09
Jun 21	4.85
May 21	5.47
May 21	5.96
May 21	6.19
May 21	6.92
Apr 21	9.17
Apr 21	8.75
Apr 21	7.76
Apr 21	8.23
Apr 21	9.11
Mar 21	9.46
Mar 21	9.52
Mar 21	6.18
Mar 21	6.01
Feb 21	6.29
Feb 21	8.25
Feb 21	8.8
Feb 21	9.62
Jan 21	10.29
Jan 21	131.58
Jan 21	113.41
Jan 21	122.77

No video analysis for this stock yet. Request one from our team.

News: IZOZF

newsfilecorp.com · 2 Jul 2026

Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC

Vancouver, British Columbia and Casablanca, Morocco--(Newsfile Corp. - July 2, 2026) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic", or the "Company"), a medical device company commercializing IzoView, a dedicated breast CT imaging system for the more accurate screening and diagnosis of breast cancers, announces that, further to its April 29, 2026 announcement, it has executed the Formal Agreement (the "Formal Agreement") with Izotropic Africa ("IZAF"), together with the Distribution Agreement and Shareholders' Agreement, establishing the definitive commercial, operational, and governance framework for the commercialization of IzoView throughout Africa and the Gulf Cooperation Council ("GCC") (collectively, the "Territory"). The Formal Agreement finalizes the ownership of Izotropic Africa, with 51% owned by IZAF shareholders and 49% owned by Izotropic and appoints IZAF as Izotropic's exclusive distributor and commercialization partner throughout the Territory.

AI Analysis

Izotropic Corporation

Video analysis: IZOZF

News: IZOZF

Izotropic Executes Formal Agreement with Izotropic Africa for Exclusive Distribution Throughout Africa and the GCC

Similar companies